Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PlasmaChem GmbH is a Berlin-based nanotechnology company specializing in the production and functionalization of nanomaterials for life science and industrial applications. The company is a pioneer in detonation nanodiamond technology, offering specialized solutions for targeted drug delivery, bio-imaging, and medical device coatings. PlasmaChem's portfolio includes a wide range of nanoparticles, quantum dots, and nanocomposites designed to enhance the efficacy and safety of therapeutic agents. Their expertise extends to surface modification, enabling the development of biocompatible materials for advanced diagnostics and regenerative medicine. The company actively collaborates with academic and industrial partners through international research initiatives to advance nanomedicine. Their products are utilized globally in research and development for oncology, infectious diseases, and diagnostic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PlasmaChem.